How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?
- 1 October 2009
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 11 (10) , 681-687
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)European Journal of Cancer, 2008
- Prognostic factors and outcome in women with uterine sarcomaEuropean Journal of Surgical Oncology, 2007
- Systemic therapy for advanced uterine sarcoma: A systematic review of the literatureGynecologic Oncology, 2005
- Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterusGynecologic Oncology, 2004
- Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid typeHistopathology, 2004
- Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999Gynecologic Oncology, 2004
- Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcomaCancer, 2000
- Retrospective analysis of 318 cases of uterine sarcomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Uterine Sarcomas: A Clinicopathologic StudyOncology, 1988
- Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteriAmerican Journal of Roentgenology, 1976